Dr. Adeera Levin
Dr. Adeera LevinCo-Principal Investigator
Professor, University of British Columbia
Executive Director, BC Provincial Renal Agency
Past-President, International Society of Nephrology

Dr. Adeera Levin is Professor of Medicine and Head of the Division of Nephrology at University of British Columbia. She is the Executive Director of the BC Provincial Agency, responsible for the planning, and delivery of kidney services in BC. She was Co-director of the Clinical Investigator Training Program at UBC, and is Curriculum Chair of the KRESCENT program , a unique pan-Canadian training program for Kidney Scientists, co funded by CIHR, Kidney Foundation of Canada and Canadian Society of Nephrology.

Her research interests are in early CKD, variability of progression and co-morbidities, health care delivery and outcomes research. She has contributed to the understanding of CKD trajectories, definitions and clinical care through numerous research activities and guideline development work. Dr. Levin is the principal investigator of a pan-Canadian study, Can-PREDDICT: Prediction of dialysis, death and interim cardiovascular events in CKD: a cohort study of over 2500 patients with biosamples followed for up to 5 years. She was the national lead for SHARP, and is currently the co lead for CREDENCE.

Dr. Levin has won numerous awards for teaching and research. She is a recipient of the Order of Canada and has received the Kidney Foundation of Canada Medal for Research Excellence and the Aubrey J. Tingle Prize in recognition of a body of work which has impacted patients in BC and elsewhere. She was inducted in the Canadian Academy for Health Sciences in 2014. She was elected President of the International Society of Nephrology 2015-17.

Dr. Braden Manns
Dr. Braden MannsCo-Principal Investigator
Svare Professor in Health Economics, University of Calgary
Scientific Director, Alberta Health Services Kidney Strategic Clinical Network

Dr. Braden Manns is a Professor in Health Economics, a Kidney Specialist at the University of Calgary and the Associate Chief Medical Officer for the Alberta Health Services’ Strategic Clinical Networks. He has experience in pharmaceutical priority setting, including a term as Chair of Canadian Expert Drug Advisory Committee, and patient oriented research. His research expertise is in applied health economics. Current research interests include examining the implications of patient-borne costs on care and outcomes in chronic disease, examining the cost effectiveness of health care policies for managing patients with chronic disease, and assessing the implications of different ways to pay physicians.

Dr. James Scholey
Dr. James ScholeyCo-Principal Investigator
Professor of Medicine and Physiology, University of Toronto
Senior Scientist, Toronto General Research Institute

Dr. James Scholey is a Professor of Medicine and Physiology and a Physician Scientist in the Department of Medicine at the University of Toronto. He is also a Senior Scientist in the Toronto General Research Institute and a staff physician in the Division of Nephrology in the Department of Medicine at the University Health network and Mount Sinai Hospital.

Dr. Scholey’s research focuses on mechanism(s) responsible for the progression of chronic kidney disease with a special interest in diabetic nephropathy and the renin angiotensin system. His laboratory employs cell-based and murine models of kidney injury. He also has a longstanding interest in the physiology of human diabetic kidney hyperfiltration and the impact of proteinuria on the progression of glomerulonephritis.

Dr. Scholey’s research program in Can-SOLVE CKD is focused on the identification of kidney risk in youth with diabetes mellitus. These studies are a collaborative effort with researchers at the Hospital for Sick Children in Toronto and researchers at the Children’s Hospital Research Institute in Winnipeg.